Total Payments
$471.22
2024 Payments
$93.51
Companies
5
Transactions
19
Medicare Patients
1,246
Medicare Billing
$112,846
Payment Breakdown by Category
Food & Beverage$471.22 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $471.22 | 19 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $332.83 | 14 | $0 (2023) |
| ABBVIE INC. | $55.00 | 1 | $0 (2024) |
| Lilly USA, LLC | $44.88 | 2 | $0 (2022) |
| Astellas Pharma US Inc | $22.18 | 1 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $16.33 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $93.51 | 3 | ABBVIE INC. ($55.00) |
| 2023 | $188.31 | 8 | Boehringer Ingelheim Pharmaceuticals, Inc. ($188.31) |
| 2022 | $189.40 | 8 | Boehringer Ingelheim Pharmaceuticals, Inc. ($144.52) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Central Nervous System | ||||||
| 06/20/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $55.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Biological | ||||||
| 11/21/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.53 | General |
| Category: DIABETES | ||||||
| 10/16/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: DIABETES | ||||||
| 09/18/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: DIABETES | ||||||
| 07/11/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: DIABETES | ||||||
| 07/10/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: DIABETES | ||||||
| 04/18/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: DIABETES | ||||||
| 04/17/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.86 | General |
| Category: DIABETES | ||||||
| 01/19/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: DIABETES | ||||||
| 09/13/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: DIABETES | ||||||
| 08/22/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Diabetes | ||||||
| 08/18/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: DIABETES | ||||||
| 08/11/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: DIABETES | ||||||
| 07/21/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: DIABETES | ||||||
| 07/07/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: DIABETES | ||||||
| 06/15/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: DIABETES | ||||||
| 04/30/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 402 | 617 | $80,726 | $36,438 |
| 2022 | 9 | 655 | 1,019 | $134,023 | $60,806 |
| 2021 | 6 | 189 | 284 | $44,434 | $15,603 |
Total Patients
1,246
Total Services
1,920
Medicare Billing
$112,846
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 228 | 400 | $60,000 | $26,535 | 44.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 48 | 48 | $7,830 | $4,017 | 51.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 53 | 89 | $7,120 | $3,881 | 54.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 11 | 11 | $1,866 | $1,393 | 74.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 41 | 46 | $1,610 | $386.40 | 24.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 21 | 23 | $2,300 | $225.96 | 9.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 266 | 397 | $59,550 | $30,330 | 50.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 109 | 237 | $18,960 | $11,708 | 61.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 82 | 82 | $13,377 | $8,090 | 60.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 19 | 81 | $16,200 | $3,065 | 18.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 23 | 23 | $3,901 | $3,019 | 77.4% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 46 | 66 | $13,200 | $2,694 | 20.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 17 | 27 | $2,460 | $1,281 | 52.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 39 | 41 | $4,100 | $427.21 | 10.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 54 | 65 | $2,275 | $192.39 | 8.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 62 | 68 | $10,200 | $4,837 | 47.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 43 | 78 | $5,262 | $3,494 | 66.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 35 | 36 | $5,873 | $2,845 | 48.4% |
| 99457 | Remote physiologic monitoring treatment management services, health care professional time in a calendar month requiring interactive communication with the patient/caregiver; first 20 minutes | Office | 2021 | 19 | 56 | $11,200 | $2,267 | 20.2% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2021 | 11 | 27 | $8,100 | $1,375 | 17.0% |
| 87811 | Sars-cov-2 covid19 w/optic | Office | 2021 | 19 | 19 | $3,800 | $786.22 | 20.7% |
About Anne Lee
Anne Lee is a Clinic/Center healthcare provider based in Flushing, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/18/2015. The National Provider Identifier (NPI) number assigned to this provider is 1205205374.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Anne Lee has received a total of $471.22 in payments from pharmaceutical and medical device companies, with $93.51 received in 2024. These payments were reported across 19 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($471.22).
As a Medicare-enrolled provider, Lee has provided services to 1,246 Medicare beneficiaries, totaling 1,920 services with total Medicare billing of $112,846. Data is available for 3 years (2021–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinic/Center
- Location Flushing, NY
- Active Since 09/18/2015
- Last Updated 09/18/2015
- Taxonomy Code 261Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1205205374
Products in Payments
- JARDIANCE (Drug) $358.56
- CREON (Drug) $55.00
- Veozah (Drug) $22.18
- MOUNJARO (Drug) $19.15
- Austedo XR (Drug) $16.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.